Drug intelligence / Profile preview

Jianyanling Capsules

Development stage: Unknown
Lead developer: Lei Yun Shang
Administration: Oral

Overview

Jianyanling Capsules (健延龄胶囊) is a Traditional Chinese Medicine (TCM) developed and manufactured by Changshu Leiyunshang Pharmaceutical. The formulation is composed of several botanical extracts, typically including *Panax ginseng*, *Astragalus membranaceus*, *Polygonum multiflorum*, *Lycium barbarum*, and *Rehmannia glutinosa*. It is designed to tonify the kidneys, nourish the blood, and strengthen the spleen and heart. The drug is primarily indicated for the treatment of symptoms associated with aging and general physical decline, such as fatigue, dizziness, palpitations, and insomnia, which are attributed to Qi and blood deficiency in TCM theory. It is approved and marketed in China as an over-the-counter (OTC) pharmaceutical product.

Brand names: Jianyanling Capsules健延龄胶囊
Other names: Jian Yan Ling Jiao Nang

Beyond the preview

Go deeper on Jianyanling Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianyanling Capsules.

Explore the full profile